rss
Br J Ophthalmol 2003;87:1235-1237 doi:10.1136/bjo.87.10.1235
  • Clinical science
    • Extended reports

A randomised clinical trial comparing 2% econazole and 5% natamycin for the treatment of fungal keratitis

  1. N V Prajna1,
  2. R K John1,2,
  3. P K Nirmalan1,2,
  4. P Lalitha1,
  5. M Srinivasan1
  1. 1Aravind Eye Care System, Madurai, India
  2. 2Lions Aravind Institute of Community Ophthalmology, Madurai, India
  1. Correspondence to: N Venkatesh Prajna, Cornea Service, Aravind Eye Care System, 1 Anna Nagar, Madurai-625020, India; prajna{at}aravind.org
  • Accepted 18 February 2003

Abstract

Aim: To compare 2% econazole and 5% natamycin in the management of fungal keratitis.

Methods: A randomised clinical trial was performed using 2% econazole or 5% natamycin as the two treatment arms on patients presenting with culture positive fungal keratitis to the cornea service at Aravind Eye Care System, Madurai, India.

Results: 116 patients were recruited, and 112 continued in the study. There were no significant differences between the two arms at baseline or for success (defined as a healed or healing ulcer) at final visit (p = 0.79).

Conclusions: 2% Econazole appears to be as effective as 5% natamycin for the management of fungal keratitis.

Footnotes

  • Financial interest: None

This Article

  1. Abstract
  2. Full text
  3. PDF

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.